Microorganisms (Aug 2020)

Compassionate Use of Cefiderocol to Treat a Case of Prosthetic Joint Infection Due to Extensively Drug-Resistant <i>Enterobacter hormaechei</i>

  • Soline Siméon,
  • Laurent Dortet,
  • Frédérique Bouchand,
  • Anne-Laure Roux,
  • Rémy A. Bonnin,
  • Clara Duran,
  • Jean-Winoc Decousser,
  • Simon Bessis,
  • Benjamin Davido,
  • Grégory Sorriaux,
  • Aurélien Dinh

DOI
https://doi.org/10.3390/microorganisms8081236
Journal volume & issue
Vol. 8, no. 8
p. 1236

Abstract

Read online

We report the case of a 67-year old man with a right knee prosthetic joint infection due to extensively drug-resistant Enterobacter hormaechei. The resistance phenotype was due to the overproduction of the intrinsic cephalosporinase (ACT-5) associated with the production of three acquired β-lactamases (CTX-M-15, TEM-1B and OXA-1), and a putative membrane decreased permeability. He was first treated with colistin-tigecyclin due to adverse drug reactions; treatment was switched to cefiderocol for a 12-week antibiotic duration, with a favorable outcome.

Keywords